Company intelligence / Profile preview
Navigo Proteins
Halle (Saale), Saxony-Anhalt, Germanynavigo-proteins.com ↗
- Ownership
- Private
- Employees
- ~70
- Development stage
- Other
01
Overview
Navigo Proteins has developed a proprietary scaffold-protein platform ("Affilin®") enabling the creation of highly selective binding proteins used both as next-generation biotherapeutics—especially radioligand conjugates—and as custom affinity ligands for industrial-scale purification of biologics. Their preclinical portfolio demonstrates strong tumor-specific accumulation and favorable biodistribution in targeted oncology applications. No clinical results have been published yet.
- Therapeutic areas
- Oncology
- Modalities
- Scaffold protein-based affinity ligandsRecombinant proteinPeptides (Affilin® proteins combine features of antibodies and peptides)Radiopharmaceuticals (radioligand conjugates)
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
ITM Isotope Technologies Munich SE (“ITM”) – collaboration on radiopharmaceutical developmentVERAXA Biotech – research collaboration on drug discovery platforms involving antibody-drug conjugates and novel antibody formats
Beyond the preview
Go deeper on Navigo Proteins.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Navigo Proteins.